EuBiologics Co.,Ltd

Quick facts

Phase 3 pipeline

• ATGC-100 100U · Cardiovascular / Hematology
  ATGC-100 is an antithrombin-based therapeutic that enhances natural anticoagulation pathways.
• Botox 100U · Neurology, Dermatology, Aesthetics
  Botox (botulinum toxin type A) blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.
• ChAdOx1 nCoV-19 · Immunology / Infectious Disease
  ChAdOx1 nCoV-19 is a viral vector vaccine that delivers the SARS-CoV-2 spike protein gene into cells to trigger an immune response against COVID-19.
• EuCorVac-19 · Immunology / Infectious Disease
  EuCorVac-19 is a recombinant protein subunit vaccine that stimulates immune responses against SARS-CoV-2 by presenting viral spike protein antigens.
• Euvichol · Other

Phase 2 pipeline

• Typbar-TCV™

Phase 1 pipeline

• ATGC-100
• EuHZV
• EuNmCV-5
• EuPCV15
• EuRSV
• EuTCV

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• EuBiologics Co.,Ltd portfolio CI brief
• EuBiologics Co.,Ltd pipeline updates RSS